Volume | 565,171 |
|
|||||
News | - | ||||||
Day High | 30.055 | Low High |
|||||
Day Low | 28.08 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Disc Medicine Inc | IRON | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
29.98 | 28.08 | 30.055 | 28.69 | 30.02 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
11,279 | 565,171 | US$ 28.72 | US$ 16,232,606 | - | 24.89 - 77.60 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:48:37 | 80 | US$ 28.70 | USD |
Disc Medicine (IRON) Options Flow Summary
Disc Medicine Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
305.62M | 24.14M | - | 0 | -76.43M | -3.17 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Disc Medicine News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IRON Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 31.99 | 32.55 | 28.08 | 30.59 | 346,397 | -3.30 | -10.32% |
1 Month | 60.76 | 62.69 | 25.60 | 35.03 | 803,686 | -32.07 | -52.78% |
3 Months | 63.37 | 77.60 | 25.60 | 48.09 | 459,229 | -34.68 | -54.73% |
6 Months | 46.85 | 77.60 | 25.60 | 51.58 | 343,589 | -18.16 | -38.76% |
1 Year | 25.20 | 77.60 | 24.89 | 49.98 | 271,951 | 3.49 | 13.85% |
3 Years | 20.89 | 77.60 | 15.00 | 47.44 | 230,157 | 7.80 | 37.34% |
5 Years | 20.89 | 77.60 | 15.00 | 47.44 | 230,157 | 7.80 | 37.34% |
Disc Medicine Description
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of innovative therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The firm's pipeline includes investigational product candidates that affect heme biosynthesis and iron metabolism. |